Prostaglandin E1 does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting ☆

[1]  S. Kozek-Langenecker,et al.  Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1. , 1998 .

[2]  P. Mongan,et al.  Tranexamic Acid and Aprotinin Reduce Postoperative Bleeding and Transfusions During Primary Coronary Revascularization , 1998, Anesthesia and analgesia.

[3]  A. Laupacis,et al.  Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery: Meta-Analyses Using Perioperative Blood Transfusion As the Outcome , 1997, Anesthesia and analgesia.

[4]  P. Dryden,et al.  Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery. , 1997, Circulation.

[5]  P. Mongan,et al.  Tranexamic Acid Is Effective in Decreasing Postoperative Bleeding and Transfusions in Primary Coronary Artery Bypass Operations: A Double-Blind, Randomized, Placebo-Controlled Trial , 1997, Anesthesia and Analgesia.

[6]  H. Sadeghi,et al.  Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[7]  K. Laczika,et al.  Prostaglandin E1 inhibits platelet decrease after massive blood transfusions during major surgery: influence on coagulation cascade? , 1997, The Journal of trauma.

[8]  G. Laufer,et al.  Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results. , 1997, European heart journal.

[9]  H. Riess,et al.  Evidence that intraoperative prostaglandin E1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation. , 1993, Transplantation.

[10]  R. Rossaint,et al.  Influence of Prostaglandin E1 Infusion on Hemostasis in Orthotopic Liver Transplantation , 1993, Seminars in thrombosis and hemostasis.

[11]  D. Roberts,et al.  Effects of Alprostadil Infusion During Extracorporeal Circulation on Blood Rheology and Postoperative Blood Loss , 1992 .

[12]  R. Bone,et al.  The effects of prostaglandin E1 on non-pulmonary organ function during clinical acute respiratory failure. The Prostaglandin E1 Study Group. , 1991, The Journal of trauma.

[13]  M. Abecassis,et al.  Treatment of primary liver graft nonfunction with prostaglandin E1. , 1989, Transplantation.

[14]  M. Frass,et al.  PGE1 for Prevention and Treatment of ARDS After Surgery , 1989 .

[15]  M. Vassar,et al.  Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. , 1988, The American review of respiratory disease.

[16]  L. Rubin,et al.  Prostacyclin and PGE1 treatment of pulmonary hypertension. , 1987, The American review of respiratory disease.

[17]  M. Vassar,et al.  Prostaglandin E1 and Survival in Patients with the Adult Respiratory Distress Syndrome: A Prospective Trial , 1986, Annals of surgery.

[18]  Shoemaker Wc,et al.  Effects of prostaglandin E1 in adult respiratory distress syndrome. , 1986 .

[19]  J. Ritter,et al.  Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man , 1985, Nature.

[20]  A. Wood,et al.  Effect on apparent liver blood flow of histamine‐receptor blockers and inhibition of prostaglandin synthesis , 1983, Clinical pharmacology and therapeutics.

[21]  M. Freed,et al.  Prostaglandin E1 in Infants with Ductus Arteriosus–dependent Congenital Heart Disease , 1981, Circulation.

[22]  A. M. Lefer,et al.  Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. , 1980, The American journal of physiology.

[23]  P D Richardson,et al.  THE VASODILATOR ACTIONS OF ISOPRENALINE, HISTAMINE, PROSTAGLANDIN E2, GLUCAGON AND SECRETIN ON THE HEPATIC ARTERIAL VASCULAR BED OF THE DOG , 1976, British journal of pharmacology.

[24]  G. Born,et al.  Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes , 1976, Nature.

[25]  R. Horton,et al.  Metabolism of prostaglandins A1 and E1 in man. , 1975, The Journal of clinical investigation.

[26]  J. R. McCurdy,et al.  Cardiovascular effects of prostaglandin E1. , 1967, The Journal of pharmacology and experimental therapeutics.